Capital Impact Advisors’s Veracyte VCYT Stock Holding History

Capital Impact Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,767	Closed	-$482K	–	100
2024 Q1	$482K	Sell	21,767 -1,721	-7%	-$42K	0.63%	69
2023 Q4	$646K	Sell	23,488 -9,481	-29%	-$229K	0.85%	59
2023 Q3	$736K	Buy	32,969 +11,419	+53%	+$294K	1.23%	32
2023 Q2	$549K	Buy	21,550 +8,893	+70%	+$216K	0.6%	76
2023 Q1	$282K	Buy	12,657 +8,833	+231%	+$213K	0.35%	132
2022 Q4	$90.7K	Hold	3,824	–	–	0.09%	224
2022 Q3	$103K	Buy	+3,824	New	+$86K	0.1%	223
2021 Q2	–	Sell	-33,134	Closed	-$1.78M	–	140
2021 Q1	$1.78M	Sell	33,134 -146,866	-82%	-$8.46M	0.62%	67
2020 Q4	$8.81M	Buy	+180,000	New	+$8.34M	2.16%	8

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Capital Impact Advisors's VCYT Position: Q2 2024 in Review

Capital Impact Advisors sold out of Veracyte (VCYT) in Q2 2024, closing a stake of 21,767 shares — an estimated $482K sold.

Capital Impact Advisors first reported a position in VCYT in Q4 2020 and held it in 9 quarters. The position peaked at $8.81M in Q4 2020. 240 funds tracked by Wall St. Rank hold VCYT as of Q2 2024.

Capital Impact Advisors reported no remaining Veracyte position as of Q2 2024 after selling out during the quarter.
Capital Impact Advisors sold 21,767 Veracyte shares in Q2 2024, an estimated $482K.
Capital Impact Advisors first reported a position in Veracyte in Q4 2020 and held it in 9 quarters.
Capital Impact Advisors's Veracyte position peaked at $8.81M in Q4 2020.
240 funds tracked by Wall St. Rank held Veracyte as of Q2 2024.

Based on Capital Impact Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.